THN-ASO1

N/A

Report date: 2025/03/13 17:32:35
NME

Base Information

Drug NameTHN-ASO1
Drug Alias NameTHN-ASO1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionTranscription factor EB stimulants
TargetsTranscription factor EB
Therapy Area/IndicationsMacular DegenerationCharcot-Marie-Tooth DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheranexus
China Registration ClassN/A

Develop Information

Active CompaniesTheranexus
Inactive CompaniesN/A
Active IndicationsMacular DegenerationCharcot-Marie-Tooth DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A